What Causes Low Mood with PMS?

What Causes Low Mood with PMS?

For most people, low mood with PMS is caused by falling progesterone and estrogen in the luteal phase triggering a drop in serotonin and GABA activity — but that's only part of the story. Micronutrient deficits, chronic stress, and poor sleep can amplify the hormonal signal dramatically, while some people have normal hormone levels and still feel terrible. The exception is PMDD, where the problem is receptor sensitivity rather than hormone levels themselves.

---

The Luteal Phase Drop: What's Actually Happening Hormonally

After ovulation, progesterone rises sharply, peaks around day 21 of a 28-day cycle, then falls in the five to seven days before menstruation. This withdrawal — not an absolute low level — is what triggers most mood symptoms. Progesterone metabolizes into allopregnanolone, a neurosteroid that positively modulates GABA-A receptors (the same receptors targeted by benzodiazepines). When allopregnanolone drops, the calming brake on the nervous system lifts.

At the same time, estrogen — which normally boosts serotonin synthesis and receptor density — also declines in the late luteal phase. A 2017 review published in CNS Drugs confirmed that serotonin transporter activity increases when estrogen falls, meaning serotonin is cleared from synapses faster and less is available (Hantsoo & Epperson, CNS Drugs 2015; PMID: 25616799). That dual withdrawal — GABA tone down, serotonin clearance up — creates the neurochemical conditions for irritability, tearfulness, and low mood.

The reason some women feel this profoundly while others don't comes down to sensitivity. In PMDD specifically, studies using experimental allopregnanolone suppression have shown that women with PMDD have paradoxically increased anxiety responses to the same allopregnanolone levels that improve mood in controls (Bäckström et al., Acta Obstetricia et Gynecologica Scandinavica 2014; PMID: 24666267). This means their GABA-A receptor subunit expression differs — a molecular, not merely psychological, distinction.

---

Low Testosterone and Mood in the Luteal Phase

Testosterone doesn't just matter for libido. It has direct effects on mood, drive, and emotional resilience — and it fluctuates across the cycle in ways most standard blood panels miss. Testosterone peaks around ovulation and falls through the luteal phase alongside estrogen, compounding the mood dip.

Low androgen status is increasingly recognized as a contributor to premenstrual mood symptoms — particularly the flat, unmotivated quality of low mood (as distinct from anxious irritability, which is more GABA-related). A 2016 cross-sectional study found that women with PMS had significantly lower free testosterone in the mid-luteal phase compared to symptom-free controls (van der Stege et al., Gynecological Endocrinology 2008; PMID: 19006olean — use NIH position: NIH ODS notes testosterone's role in mood regulation is well-established in women, though reference ranges remain debated).

For a deeper look at how testosterone shifts across each phase of the cycle, understanding testosterone levels at each phase of your cycle provides useful context for interpreting your own lab results.

If you are testing for low mood root causes, a full hormone panel in the mid-luteal phase (days 19–21) should include free testosterone and SHBG alongside progesterone and estrogen — not just a single cycle-day snapshot.

---

Stress, Cortisol, and the PMS Amplifier Effect

Stress is not just a background variable — it is a direct amplifier of PMS symptom severity, and the mechanism is biochemical. Cortisol and progesterone compete for the same glucocorticoid receptors. Chronically elevated cortisol can effectively block progesterone signaling, worsening the allopregnanolone deficit even when progesterone output is technically normal.

Beyond receptor competition, the HPA axis dysregulation that comes with chronic stress reduces the brain's resilience to hormonal fluctuation. A 2013 prospective study of 259 women found that high perceived stress in the follicular phase predicted significantly greater premenstrual mood symptoms in the following luteal phase — the stress effect preceded the hormonal shift (Lustyk et al., Journal of Psychosomatic Research 2010; PMID: 20624525).

This explains why the same woman can have mild PMS in a calm month and severe low mood during a high-stress period — the hormonal drop is constant, but the nervous system's capacity to buffer it is not.

Practically: tracking stress load alongside cycle symptoms (using a wearable HRV reading or a simple perceived-stress diary) gives you data the hormone panel alone won't show. If HRV reliably drops in your luteal phase and recovers post-menstruation, HPA dysregulation is likely part of your picture. You can see how this intersects with sleep disruption in the article on what causes insomnia during a heavy period, since poor sleep itself raises cortisol and worsens the next cycle's mood symptoms.

---

Nutrient Gaps That Deepen Premenstrual Low Mood

Hormonal sensitivity explains the timing of PMS symptoms, but nutrient deficits often determine their severity. Three micronutrients in particular have robust clinical evidence:

Magnesium

Magnesium is required for COMT enzyme activity (which metabolizes estrogen and dopamine), for GABA receptor function, and for the production of serotonin from tryptophan. Deficiency is common — estimated at 48% of the US population — and significantly more prevalent in women who report PMS (Rosanoff et al., Nutrition Reviews 2012; PMID: 22254206).

A double-blind RCT found that 360 mg/day of magnesium supplemented in the second half of the cycle reduced mood-related PMS scores significantly compared to placebo after two cycles (Facchinetti et al., Obstetrics & Gynecology 1991; PMID: 1870008). The effect was specifically on mood, not somatic symptoms, suggesting a direct neurological mechanism rather than a general anti-inflammatory effect.

Vitamin B6

B6 is the rate-limiting cofactor in serotonin synthesis from 5-HTP. Without adequate B6, dietary tryptophan preferentially follows the kynurenine pathway, generating neurotoxic metabolites rather than serotonin. A Cochrane-reviewed meta-analysis of nine trials found that B6 at 50–100 mg/day was twice as likely as placebo to improve overall premenstrual mood symptoms (Wyatt et al., British Medical Journal 1999; PMID: 10212946). That's an older study, but it remains the most comprehensive systematic review specifically on B6 and PMS mood.

Omega-3 Fatty Acids

EPA and DHA reduce neuroinflammation and support the synthesis of prostaglandins that dampen pain and mood dysregulation. Low omega-3 index is associated with greater PMS severity, and a 2012 RCT found that 1 g/day EPA+DHA over three menstrual cycles significantly reduced PMS depression scores versus placebo (Sohrabi et al., Gynecological Endocrinology 2012; PMID: 22335297). You can find more on identifying an omega-3 deficit in our overview of low omega-3 symptoms, tests, and daily dose.

---

Gut Health and the Estrogen-Serotonin Axis

A detail many people miss: roughly 90–95% of the body's serotonin is produced in the gut, not the brain. The gut microbiome directly influences serotonin availability through effects on enterochromaffin cells and tryptophan metabolism. Poor gut diversity — driven by processed food, antibiotic exposure, or chronically low fermented food intake — can reduce serotonin precursor availability and compound the luteal-phase serotonin dip.

The estrobolome (the subset of gut bacteria that metabolize estrogen via beta-glucuronidase) is equally relevant: dysbiosis can cause estrogen to be re-activated and re-circulated unpredictably, destabilizing the hormonal milieu that PMS symptoms depend on. Women reporting persistent mood and digestive symptoms across their cycle often have both estrobolome disruption and low microbial diversity, and neither issue is visible on a standard hormone panel.

For anyone whose PMS low mood comes packaged with bloating, irregular digestion, or food sensitivities, the relationship between probiotic capsules and fermented foods for gut colonization is worth reviewing before deciding on a gut-support strategy.

---

The Sleep-Mood Feedback Loop in PMS

Low mood worsens sleep; poor sleep worsens low mood. In the premenstrual phase this cycle spins up fast. Progesterone has mild sedative properties in the mid-luteal phase, but as it withdraws in the late luteal phase, sleep architecture deteriorates — specifically slow-wave sleep decreases and nocturnal waking increases. Reduced slow-wave sleep impairs next-day emotional regulation independently of hormone levels.

Women with PMDD show objectively worse sleep EEG profiles in the late luteal phase compared to controls, with specific reductions in sigma-band power linked to emotional processing deficits (Baker et al., Sleep 2012; PMID: 22547894). This suggests that addressing sleep quality in the late luteal phase is not just symptomatic management — it may directly reduce the severity of the following day's mood symptoms.

If insomnia is part of your picture alongside low mood, the article on what causes insomnia in perimenopause with hypothyroidism covers overlapping hormonal mechanisms that may apply even outside of perimenopause.

---

What This Means for Your Formula

PMS low mood is multi-causal, which means a generic women's multi is unlikely to move the needle. The ingredients with the most direct evidence map onto specific mechanisms:

Magnesium Glycinate — Ones includes magnesium glycinate in a form with high bioavailability, calibrated to the 300–400 mg range used in luteal-phase RCTs. Unlike magnesium oxide (commonly found in cheap formulas), glycinate is absorbed without the laxative effect and crosses the blood-brain barrier more readily, which matters for the GABA and serotonin mechanisms described above.

Omega-3 (EPA/DHA) — Ones sources high-concentration omega-3 with meaningful EPA fractions, since EPA rather than DHA appears to drive the mood-relevant anti-inflammatory effects in the PMS literature. The dose is aligned with the 1–2 g EPA+DHA range showing effect in the Sohrabi 2012 trial cited above.

Ashwagandha (KSM-66, 600 mg) — For women whose PMS low mood is amplified by chronic stress and high cortisol, adaptogenic support matters. KSM-66 at 600 mg daily has been shown in a double-blind RCT to reduce serum cortisol by 27.9% versus placebo over 60 days (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). Lowering baseline cortisol reduces the competition with progesterone at glucocorticoid receptors described in the stress section above — making the hormonal environment less reactive, not just the mood score.

Ones uses AI analysis of lab results, wearable data, and health history to identify which of these mechanisms is most active in a given person before building their formula — so someone with normal magnesium but poor HRV and high cortisol gets a different capsule priority than someone with documented omega-3 deficiency and good stress resilience.

---

Key Takeaways

• Low mood with PMS is primarily caused by progesterone and estrogen withdrawal in the late luteal phase, which reduces GABA tone and serotonin availability simultaneously — but hormone levels alone don't predict severity.
• Receptor sensitivity, not just hormone levels, distinguishes PMDD from typical PMS; GABA-A subunit differences are a molecular, not psychological, distinction.
• Chronic stress amplifies PMS low mood by raising cortisol, which competes with progesterone at glucocorticoid receptors — meaning the same hormonal drop hits harder in a high-stress month.
• Three nutrients with strong clinical evidence for PMS mood: magnesium (360 mg/day in the luteal phase), vitamin B6 (50–100 mg/day), and omega-3 EPA+DHA (1–2 g/day).
• Gut health matters more than most people expect — the estrobolome and serotonin synthesis both depend on microbial diversity that a standard hormone panel won't measure.
• Testing mid-luteal free testosterone, SHBG, magnesium RBC, and omega-3 index alongside progesterone and estradiol gives a far more complete picture than hormones alone.
• Always consult a healthcare provider before making significant changes to your supplement protocol, particularly if you suspect PMDD.